Insider Stock Trading History of Berger Franklin M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Berger Franklin M since year 2005. The trader's CIK number is 1273885. At the time of this reporting, Berger Franklin M is the Director of Immune Design Corp. . (stock ticker symbol IMDZ). See this page for all insider trading activities at Immune Design Corp. .

Note that in the past BERGER FRANKLIN M also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Berger Franklin M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-12-16 IMDZ Immune Design Corp. Sale 50,000 6.55 327,350
2016-12-15 PTI Proteostasis Therapeutics, Inc. Buy 26,000 10.99 285,636
2016-12-16 PTI Proteostasis Therapeutics, Inc. Buy 14,000 11.52 161,336
2016-09-14 PTI Proteostasis Therapeutics, Inc. Buy 69,230 13.00 899,990
2016-04-22 FPRX Five Prime Therapeutics Inc Buy 5,000 49.54 247,700
2016-04-19 FPRX Five Prime Therapeutics Inc Buy 6,090 46.98 286,138
2016-02-17 PTI Proteostasis Therapeutics, Inc. Buy 25,000 8.00 200,000
2015-09-22 FPRX Five Prime Therapeutics Inc Option Ex 12,500 12.70 158,750
2015-09-02 FPRX Five Prime Therapeutics Inc Option Ex 8,130 7.88 64,023
2015-07-01 FPRX Five Prime Therapeutics Inc Option Ex 6,504 6.21 40,422
2015-06-17 FPRX Five Prime Therapeutics Inc Option Ex 9,756 6.89 67,218
2015-04-21 IMDZ Immune Design Corp. Buy 25,000 26.50 662,500
2015-01-28 FPRX Five Prime Therapeutics Inc Buy 25,000 27.03 675,750
2015-01-14 FPRX Five Prime Therapeutics Inc Buy 5,000 26.58 132,890
2015-01-15 FPRX Five Prime Therapeutics Inc Buy 5,049 25.76 130,067
2014-11-28 FPRX Five Prime Therapeutics Inc Buy 1,951 21.04 41,045
2014-07-29 IMDZ Immune Design Corp. Buy 50,000 12.00 600,000
2014-02-21 SGEN Seattle Genetics Inc /wa Option Ex 7,500 12.76 95,700
2013-08-28 SGEN Seattle Genetics Inc /wa Option Ex 10,000 12.76 127,600
2013-08-20 BTX Biotime Inc Buy 500 3.71 1,854
2012-08-23 SGEN Seattle Genetics Inc /wa Option Ex 20,000 10.14 202,800
2011-06-22 SGEN Seattle Genetics Inc /wa Buy 7,000 20.04 140,273
2010-10-01 SGEN Seattle Genetics Inc /wa Option Ex 5,000 8.38 41,900
2010-08-24 SGEN Seattle Genetics Inc /wa Option Ex 13,000 7.71 100,165
2010-05-14 SGEN Seattle Genetics Inc /wa Option Ex 17,000 7.03 119,510
2010-05-13 SGEN Seattle Genetics Inc /wa Buy 5,000 13.37 66,865
2010-03-30 SGEN Seattle Genetics Inc /wa Buy 11,500 12.05 138,529
2010-03-10 SGEN Seattle Genetics Inc /wa Buy 8,000 11.99 95,920
2010-03-12 SGEN Seattle Genetics Inc /wa Buy 5,000 11.76 58,795
2009-12-29 SGEN Seattle Genetics Inc /wa Option Ex 10,000 5.11 51,100
2009-10-07 SGEN Seattle Genetics Inc /wa Option Ex 5,000 4.18 20,900
2009-07-29 SGEN Seattle Genetics Inc /wa Option Ex 5,000 4.18 20,900
2008-01-22 SGEN Seattle Genetics Inc /wa Buy 528 9.12 4,815

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berger Franklin M (Director of Immune Design Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.